MedPath

Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

Not Applicable
Conditions
Testosterone Deficiency
Estrogen Deficiency
Interventions
Device: Joovv Infrared Light Device
Registration Number
NCT04245527
Lead Sponsor
ProofPilot
Brief Summary

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • United States resident
Exclusion Criteria
  • current Joovv or other photomodulation therapy user
  • under medical supervision for medically treatable illness
  • significant travel during study period
  • use of birth control

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Study ArmJoovv Infrared Light Device20 minutes Joovv Solo every day for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Testosterone Changebaseline to week 8

in males, change from baseline to week 8

change of thyroid-stimulating hormone (TSH)baseline to week 8

in females change in estrogen and progesterone from baseline to week 8

Self report general wellnessbaseline to week 8

series of questions at baseline and week 8 on general wellness (modified Short Form-36)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ProofPilot (Virtual Study: https://p.proofpilot.com)

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath